Medical Properties Trust Stock-Based Compensation Growth & History (MPT)
Medical Properties Trust's stock-based compensation was $25.7M for fiscal 2025.
View full Medical Properties Trust company overviewMedical Properties Trust annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $25.7M | −$7.2M | −21.93% |
| 2024 | 2024-12-31 | $33.0M | −$274,000 | −0.82% |
| 2023 | 2023-12-31 | $33.3M | −$16.2M | −32.72% |
| 2022 | 2022-12-31 | $49.4M | −$2.7M | −5.16% |
| 2021 | 2021-12-31 | $52.1M | $5.0M | +10.51% |
| 2020 | 2020-12-31 | $47.2M | $15.0M | +46.50% |
| 2019 | 2019-12-31 | $32.2M | $15.7M | +95.02% |
| 2018 | 2018-12-31 | $16.5M | $6.6M | +65.90% |
| 2017 | 2017-12-31 | $9.9M | $2.0M | +25.27% |
| 2016 | 2016-12-31 | $7.9M | −$3.2M | −28.59% |
| 2015 | 2015-12-31 | $11.1M | $2.0M | +21.35% |
| 2014 | 2014-12-31 | $9.2M | $332,000 | +3.76% |
| 2013 | 2013-12-31 | $8.8M | $1.2M | +15.66% |
| 2012 | 2012-12-31 | $7.6M | $654,000 | +9.37% |
| 2011 | 2011-12-31 | $7.0M | $367,000 | +5.55% |
| 2010 | 2010-12-31 | $6.6M | $1.1M | +20.55% |
| 2009 | 2009-12-31 | $5.5M | — | — |
Medical Properties Trust quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.9M | $4.0M | +467.21% |
| Q1 2026 | 2026-03-31 | $573,000 | −$17.1M | −96.76% |
| Q4 2025 | 2025-12-31 | −$5.1M | −$7.5M | — |
| Q3 2025 | 2025-09-30 | $12.3M | −$2.1M | −14.45% |
| Q2 2025 | 2025-06-30 | $857,000 | −$7.7M | −89.94% |
| Q1 2025 | 2025-03-31 | $17.7M | $10.0M | +131.43% |
| Q4 2024 | 2024-12-31 | $2.4M | −$1.1M | −32.17% |
| Q3 2024 | 2024-09-30 | $14.4M | $3.0M | +25.97% |
| Q2 2024 | 2024-06-30 | $8.5M | $2.1M | +32.38% |
| Q1 2024 | 2024-03-31 | $7.6M | −$4.2M | −35.47% |
| Q4 2023 | 2023-12-31 | $3.5M | −$12.9M | −78.50% |
| Q3 2023 | 2023-09-30 | $11.5M | $364,000 | +3.28% |
| Q2 2023 | 2023-06-30 | $6.4M | −$3.7M | −36.32% |
| Q1 2023 | 2023-03-31 | $11.8M | $25,000 | +0.21% |
| Q4 2022 | 2022-12-31 | $16.4M | $2.9M | +21.45% |
| Q3 2022 | 2022-09-30 | $11.1M | −$2.5M | −18.19% |
| Q2 2022 | 2022-06-30 | $10.1M | −$2.7M | −20.85% |
| Q1 2022 | 2022-03-31 | $11.8M | −$460,000 | −3.75% |
| Q4 2021 | 2021-12-31 | $13.5M | $966,000 | +7.69% |
| Q3 2021 | 2021-09-30 | $13.6M | $1.2M | +9.56% |
| Q2 2021 | 2021-06-30 | $12.8M | $579,000 | +4.75% |
| Q1 2021 | 2021-03-31 | $12.3M | $2.2M | +22.20% |
| Q4 2020 | 2020-12-31 | $12.6M | $2.5M | +24.68% |
| Q3 2020 | 2020-09-30 | $12.4M | $3.3M | +36.15% |
| Q2 2020 | 2020-06-30 | $12.2M | $5.9M | +93.00% |
| Q1 2020 | 2020-03-31 | $10.0M | $3.3M | +49.46% |
| Q4 2019 | 2019-12-31 | $10.1M | $5.3M | +109.33% |
| Q3 2019 | 2019-09-30 | $9.1M | $4.1M | +82.84% |
| Q2 2019 | 2019-06-30 | $6.3M | $1.4M | +29.74% |
| Q1 2019 | 2019-03-31 | $6.7M | $4.9M | +261.80% |
| Q4 2018 | 2018-12-31 | $4.8M | $2.0M | +71.72% |
| Q3 2018 | 2018-09-30 | $5.0M | $2.2M | +79.36% |
| Q2 2018 | 2018-06-30 | $4.9M | $2.5M | +102.37% |
| Q1 2018 | 2018-03-31 | $1.9M | −$115,000 | −5.83% |
| Q4 2017 | 2017-12-31 | $2.8M | $691,000 | +32.75% |
| Q3 2017 | 2017-09-30 | $2.8M | $1.1M | +64.94% |
| Q2 2017 | 2017-06-30 | $2.4M | $274,000 | +12.85% |
| Q1 2017 | 2017-03-31 | $2.0M | −$49,000 | −2.43% |
| Q4 2016 | 2016-12-31 | $2.1M | −$629,000 | −22.96% |
| Q3 2016 | 2016-09-30 | $1.7M | −$1.1M | −38.64% |
| Q2 2016 | 2016-06-30 | $2.1M | −$688,000 | −24.40% |
| Q1 2016 | 2016-03-31 | $2.0M | −$805,000 | −28.50% |
| Q4 2015 | 2015-12-31 | $2.7M | $145,000 | +5.59% |
| Q3 2015 | 2015-09-30 | $2.7M | $600,000 | +28.06% |
| Q2 2015 | 2015-06-30 | $2.8M | $674,000 | +31.41% |
| Q1 2015 | 2015-03-31 | $2.8M | $538,000 | +23.52% |
| Q4 2014 | 2014-12-31 | $2.6M | −$220,000 | −7.82% |
| Q3 2014 | 2014-09-30 | $2.1M | $323,000 | +17.80% |
| Q2 2014 | 2014-06-30 | $2.1M | −$139,000 | −6.08% |
| Q1 2014 | 2014-03-31 | $2.3M | $368,000 | +19.18% |
| Q4 2013 | 2013-12-31 | $2.8M | $607,000 | +27.50% |
| Q3 2013 | 2013-09-30 | $1.8M | $22,000 | +1.23% |
| Q2 2013 | 2013-06-30 | $2.3M | $506,000 | +28.44% |
| Q1 2013 | 2013-03-31 | $1.9M | $61,000 | +3.28% |
| Q4 2012 | 2012-12-31 | $2.2M | — | — |
| Q3 2012 | 2012-09-30 | $1.8M | $161,000 | +9.87% |
| Q2 2012 | 2012-06-30 | $1.8M | — | — |
| Q1 2012 | 2012-03-31 | $1.9M | $20,000 | +1.09% |
| Q3 2011 | 2011-09-30 | $1.6M | $266,000 | +19.47% |
| Q1 2011 | 2011-03-31 | $1.8M | $309,000 | +20.21% |
| Q4 2010 | 2010-12-31 | $1.4M | — | — |
| Q3 2010 | 2010-09-30 | $1.4M | — | — |
| Q2 2010 | 2010-06-30 | $2.4M | — | — |
| Q1 2010 | 2010-03-31 | $1.5M | — | — |
Medical Properties Trust stock-based compensation trends
Over the last five fiscal years, Medical Properties Trust's stock-based compensation decreased from $47.2M to $25.7M, a change of −$21.4M. The latest reported quarter, Q2 2026, shows $4.9M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medical Properties Trust source filings ↗